Daymark Wealth Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,851
| Closed | -$245K | – | 521 |
|
|
2024
Q4 | $245K | Sell |
2,851
-3,551
| -55% | -$305K | 0.01% | 447 |
|
|
2024
Q3 | $762K | Buy |
6,402
+112
| +2% | +$13.3K | 0.03% | 280 |
|
|
2024
Q2 | $898K | Buy |
6,290
+864
| +16% | +$123K | 0.04% | 247 |
|
|
2024
Q1 | $697K | Sell |
5,426
-586
| -10% | -$75.2K | 0.04% | 237 |
|
|
2023
Q4 | $622K | Sell |
6,012
-63
| -1% | -$6.52K | 0.04% | 232 |
|
|
2023
Q3 | $552K | Buy |
6,075
+353
| +6% | +$32.1K | 0.04% | 230 |
|
|
2023
Q2 | $463K | Buy |
+5,722
| New | +$463K | 0.03% | 245 |
|